Skip to content

Clinical trials

Phase 3 Atherosclerosis trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atherosclerosis Phase: Phase 3 Country / region: United Kingdom Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20081
20091
20112
20121
20161
20182
20211
20222
20242
20255
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting8
Recruiting4
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company4
Novartis Pharmaceuticals3
Amgen2
AstraZeneca2
GlaxoSmithKline2
University of Oxford2
AtheroGenics1
CSL Behring1
Eastman Dental Insitute and Hospital1
Esperion Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atherosclerosis22
Cardiovascular Diseases8
Coronary Artery Disease4
Heart Diseases4
Acute Coronary Syndrome2
Coronary Disease2
Myocardial Infarction2
Peripheral Arterial Disease2
Stroke2
Angina, Unstable1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.